BioRestorative Therapies(BRTX)
MELVILLE, NY
BiotechnologyFocus: Autologous Stem Cell Therapy
BioRestorative Therapies is a life sciences company focused on Autologous Stem Cell Therapy.
Cell TherapyGene Therapy
Funding Stage
PUBLIC
Open Jobs
1
Pipeline & Clinical Trials
BRTX-100
Lumbar Disc DiseaseClinical Trials (1)
NCT04042844A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
Phase 2Open Jobs (1)
Interview Prep Quick Facts
Portfolio: 1 clinical trial
SEC Filings: 2 available
Open Roles: 1 active job
Financials (FY2024)
Revenue
$146K22%
R&D Spend
$4M(2767%)15%
Net Income
-$10MCash
$884K